Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
Gallium (Ga) is a semimetallic element that has demonstrated therapeutic and diagnostic-imaging potential in a number of disease settings, including cancer and infectious diseases. Gallium's biological actions stem from its ionic radius being almost the same as that of ferric iron (Fe(3+)), whereby it can replace iron (Fe) in Fe(3+)-dependent biological systems, such as bacterial and mammalian Fe transporters and Fe(3+)-containing enzymes. Unlike Fe(3+), ionic gallium (Ga(3+)) cannot be reduced, and when incorporated, it inactivates Fe(3+)-dependent reduction and oxidation processes that are necessary for bacterial and mammalian cell proliferation. Most pathogenic bacteria require Fe for growth and function, and the availability of Fe in the host or environment can greatly enhance virulence. We examined whether gallium maltolate (GaM), a novel formulation of Ga, had antibacterial activity in a thermally injured acute infection mouse model. Dose-response studies indicated that a GaM dose as low as 25 mg/kg of body weight delivered subcutaneously was sufficient to provide 100% survival in a lethal P. aeruginosa-infected thermally injured mouse model. Mice treated with 100 mg/kg GaM had undetectable levels of Pseudomonas aeruginosa in their wounds, livers, and spleens, while the wounds of untreated mice were colonized with over 10(8) P. aeruginosa CFU/g of tissue and their livers and spleens were colonized with over 10(5) P. aeruginosa CFU/g of tissue. GaM also significantly reduced the colonization of Staphylococcus aureus and Acinetobacter baumannii in the wounds of thermally injured mice. Furthermore, GaM was also therapeutically effective in preventing preestablished P. aeruginosa infections at the site of the injury from spreading systemically. Taken together, our data suggest that GaM is potentially a novel antibacterial agent for the prevention and treatment of wound infections following thermal injury.
DeLeon
Katrina
K
Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA.
Balldin
Fredrik
F
Watters
Chase
C
Hamood
Abdul
A
Griswold
John
J
Sreedharan
Sunil
S
Rumbaugh
Kendra P
KP
D040981:Acinetobacter baumannii / Q000187:drug effects; D000818:Animals; D002056:Burns / Q000150:complications* / Q000382:microbiology; D005260:Female; D005708:Gallium / Q000627:therapeutic use; D051379:Mice; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011753:Pyrones / Q000627:therapeutic use*; D013211:Staphylococcus aureus / Q000187:drug effects
D009942:Organometallic Compounds; D011753:Pyrones; C512662:gallium maltolate; D005708:Gallium; C027235:gallium nitrate